Effects of Statin Therapy on Plasma Proprotein Convertase Subtilisin/kexin Type 9 and Sortilin Levels in Statin-Naive Patients with Coronary Artery Disease

Journal of Atherosclerosis and Thrombosis
Tsuyoshi NozueIchiro Michishita

Abstract

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulator of serum low-density lipoprotein (LDL) cholesterol levels, and sortilin is linked to lipoprotein metabolism. Although statin therapy increases PCSK9 levels, effects of this therapy on plasma sortilin levels have not been evaluated. The purpose of the present study was to examine the effects of statins on plasma PCSK9 and sortilin levels, and association of statin-induced increase in PCSK9 levels with sortilin. Serum lipid levels and plasma PCSK9 and sortilin levels were measured at baseline and 8 months after statin therapy in 90 statin-naive patients with coronary artery disease (CAD). Pitavastatin 4 mg/day was used to treat 44 patients and pravastatin 20 mg/day to treat the remaining 46 patients. For both statin groups, significant increases in hetero-dimer PCSK9 levels (pitavastatin: 31%, p<0.0001; pravastatin: 34%, p=0.03) and decreases in sortilin levels (pitavastatin: -8%, p=0.02; pravastatin: -16%, p=0.002) were observed. Although a reduction in LDL cholesterol was greater in the pitavastatin group than in the pravastatin group, no significant differences were observed in percentage changes in hetero-dimer PCSK9 and sortilin levels. A significant po...Continue Reading

References

Mar 20, 1999·The Journal of Biological Chemistry·M S NielsenC M Petersen
Feb 21, 2006·Trends in Endocrinology and Metabolism : TEM·Gilles LambertPhilippe Costet
Aug 18, 2006·Biological Chemistry·Nabil G SeidahAnnik Prat
Nov 3, 2006·The Journal of Clinical Investigation·Thomas A LagaceJay D Horton
Jan 12, 2007·Trends in Biochemical Sciences·Jay D HortonHelen H Hobbs
Jun 1, 2007·The Journal of Biological Chemistry·Markey C McNuttJay D Horton
Jul 5, 2007·The Biochemical Journal·Jun LiJennifer L Harris
Jul 20, 2007·The New England Journal of Medicine·Nilesh J SamaniUNKNOWN WTCCC and the Cardiogenics Consortium
Nov 24, 2007·Journal of Lipid Research·Holly E CareskeyRobert J Konrad
Jul 8, 2008·The Journal of Biological Chemistry·Stefan K NilssonGunilla Olivecrona
Nov 13, 2008·Nature Reviews. Neuroscience·Thomas E WillnowAnders Nykjaer
Dec 9, 2008·Nature Genetics·Yurii S AulchenkoUNKNOWN ENGAGE Consortium
Jan 6, 2009·Nature Structural & Molecular Biology·Esben M QuistgaardSøren S Thirup
Feb 10, 2009·Nature Genetics·UNKNOWN Myocardial Infarction Genetics ConsortiumDavid Altshuler
Mar 21, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Joseph L Goldstein, Michael S Brown
Dec 3, 2010·Current Opinion in Lipidology·Thomas E WillnowAnders Nykjaer
Mar 23, 2012·The New England Journal of Medicine·Evan A SteinGary D Swergold
Jul 4, 2012·The Journal of Clinical Investigation·Alanna StrongDaniel J Rader
Nov 2, 2012·The New England Journal of Medicine·Eli M RothEvan A Stein
Feb 11, 2014·Cell Metabolism·Camilla GustafsenSimon Glerup
Nov 21, 2014·Journal of Atherosclerosis and Thrombosis·Sha Li, Jian-Jun Li
Feb 24, 2015·Current Atherosclerosis Reports·Mads KjolbyClaus Munck Petersen

❮ Previous
Next ❯

Citations

Apr 5, 2019·Current Opinion in Lipidology·Donna M Conlon
Mar 11, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Claudia GoettschElena Aikawa
Mar 23, 2018·Journal of Geriatric Psychiatry and Neurology·Martine PaquetteRobert Dufour
Oct 19, 2019·Biological Reviews of the Cambridge Philosophical Society·Xin Su, Daoquan Peng
Feb 23, 2020·Biomarkers in Medicine·Shanshan HuangJianlei Zheng
Aug 23, 2017·Journal of Cardiovascular Pharmacology and Therapeutics·Theodosios D FilippatosMoses S Elisaf
Nov 12, 2016·International Journal of Molecular Sciences·Sophie Béraud-DufourJean Mazella
Nov 22, 2016·Expert Review of Clinical Pharmacology·T D FilippatosM S Elisaf
Aug 15, 2017·Journal of Atherosclerosis and Thrombosis·Tsuyoshi Nozue
Dec 2, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Claudia GoettschElena Aikawa
Jan 13, 2019·Cardiovascular Diabetology·Federico BiscettiAndrea Flex
Feb 23, 2021·Journal of Atherosclerosis and Thrombosis·Masatsune Ogura
May 4, 2021·Frontiers in Cardiovascular Medicine·Peter Loof MøllerMads Kjolby
Aug 14, 2021·International Journal of Clinical Practice·Zeki SimsekRegayip Zehir

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.